|
參考文獻: Alimperti, S., Lei, P., Wen, Y., Tian, J., Campbell, A. M., & Andreadis, S. T. (2014). Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential. Biotechnol Prog, 30(4), 974-983. doi:10.1002/btpr.1904 Amalric, M., & Koob, G. F. (1987). Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats. J Neurosci, 7(7), 2129-2134. Bellucci, A., Navarria, L., Zaltieri, M., Falarti, E., Bodei, S., Sigala, S., . . . Spano, P. (2011). Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease. J Neurochem, 116(4), 588-605. doi:10.1111/j.1471-4159.2010.07143.x Ben-Hur, T., Fainstein, N., & Nishri, Y. (2013). Cell-based reparative therapies for multiple sclerosis. Curr Neurol Neurosci Rep, 13(11), 397. doi:10.1007/s11910-013-0397-5 Biaggioni, I., Freeman, R., Mathias, C. J., Low, P., Hewitt, L. A., Kaufmann, H., & Droxidopa, I. (2015). Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension, 65(1), 101-107. doi:10.1161/HYPERTENSIONAHA.114.04035 Blum, D., Torch, S., Lambeng, N., Nissou, M., Benabid, A. L., Sadoul, R., & Verna, J. M. (2001). Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol, 65(2), 135-172. Bonini, N. M., & Giasson, B. I. (2005). Snaring the function of alpha-synuclein. Cell, 123(3), 359-361. doi:10.1016/j.cell.2005.10.017 Braak, H., Del Tredici, K., Rub, U., de Vos, R. A., Jansen Steur, E. N., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 24(2), 197-211. Burre, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., & Sudhof, T. C. (2010). Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science, 329(5999), 1663-1667. doi:10.1126/science.1195227 d'Anglemont de Tassigny, X., Pascual, A., & Lopez-Barneo, J. (2015). GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease. Front Neuroanat, 9, 10. doi:10.3389/fnana.2015.00010 Dang, S., Xu, H., Xu, C., Cai, W., Li, Q., Cheng, Y., . . . Zhang, Y. (2014). Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis. Autophagy, 10(7), 1301-1315. doi:10.4161/auto.28771 Danielyan, L., Schafer, R., von Ameln-Mayerhofer, A., Bernhard, F., Verleysdonk, S., Buadze, M., . . . Frey, W. H., 2nd. (2011). Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res, 14(1), 3-16. doi:10.1089/rej.2010.1130 Darios, F., Ruiperez, V., Lopez, I., Villanueva, J., Gutierrez, L. M., & Davletov, B. (2010). Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep, 11(7), 528-533. doi:10.1038/embor.2010.66 de Munter, J. P., Lee, C., & Wolters, E. (2013). Cell based therapy in Parkinsonism. Transl Neurodegener, 2(1), 13. doi:10.1186/2047-9158-2-13 de Oliveira, G. L., de Lima, K. W., Colombini, A. M., Pinheiro, D. G., Panepucci, R. A., Palma, P. V., . . . Malmegrim, K. C. (2015). Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts. Cell Transplant, 24(2), 151-165. doi:10.3727/096368913X675142 DeFrance, J. F., Sikes, R. W., & Chronister, R. B. (1985). Dopamine action in the nucleus accumbens. J Neurophysiol, 54(6), 1568-1577. Ding, D. C., Shyu, W. C., & Lin, S. Z. (2011). Mesenchymal stem cells. Cell Transplant, 20(1), 5-14. doi:10.3727/096368910x Dong, Z., Luo, L., Liao, Y., Zhang, Y., Gao, J., Ogawa, R., . . . Lu, F. (2014). In vivo injectable human adipose tissue regeneration by adipose-derived stem cells isolated from the fluid portion of liposuction aspirates. Tissue Cell, 46(3), 178-184. doi:10.1016/j.tice.2014.04.001 Emmanouilidou, E., Stefanis, L., & Vekrellis, K. (2010). Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol Aging, 31(6), 953-968. doi:10.1016/j.neurobiolaging.2008.07.008 Fernagut, P. O., & Tison, F. (2012). Animal models of multiple system atrophy. Neuroscience, 211, 77-82. doi:10.1016/j.neuroscience.2011.09.044 Fernandez, O., Arnal-Garcia, C., Arroyo-Gonzalez, R., Brieva, L., Calles-Hernandez, M. C., Casanova-Estruch, B., . . . Post, E. G. (2013). Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III). Rev Neurol, 57(7), 317-329. Fierabracci, A., Del Fattore, A., Luciano, R., Muraca, M., Teti, A., & Muraca, M. (2015). Recent advances in mesenchymal stem cell immunomodulation: the role of microvesicles. Cell Transplant, 24(2), 133-149. doi:10.3727/096368913X675728 Frolich, K., Hagen, R., & Kleinsasser, N. (2014). [Adipose-derived Stromal Cells (ASC) - Basics and Therapeutic Approaches in Otorhinolaryngology]. Laryngorhinootologie, 93(6), 369-380. doi:10.1055/s-0034-1367080 Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., . . . Gerhardt, G. A. (1996). Functional recovery in parkinsonian monkeys treated with GDNF. Nature, 380(6571), 252-255. doi:10.1038/380252a0 Glinka, Y., Gassen, M., & Youdim, M. B. (1997). Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl, 50, 55-66. Gordon, G. R., Mulligan, S. J., & MacVicar, B. A. (2007). Astrocyte control of the cerebrovasculature. Glia, 55(12), 1214-1221. doi:10.1002/glia.20543 Graham, J. G., & Oppenheimer, D. R. (1969). Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry, 32(1), 28-34. Guillemin, G. J. (2012). Quinolinic acid, the inescapable neurotoxin. FEBS J, 279(8), 1356-1365. doi:10.1111/j.1742-4658.2012.08485.x Hardy, J., Lewis, P., Revesz, T., Lees, A., & Paisan-Ruiz, C. (2009). The genetics of Parkinson's syndromes: a critical review. Curr Opin Genet Dev, 19(3), 254-265. doi:10.1016/j.gde.2009.03.008 Hassan, W. U., Greiser, U., & Wang, W. (2014). Role of adipose-derived stem cells in wound healing. Wound Repair Regen, 22(3), 313-325. doi:10.1111/wrr.12173 Hidalgo-Figueroa, M., Bonilla, S., Gutierrez, F., Pascual, A., & Lopez-Barneo, J. (2012). GDNF is predominantly expressed in the PV+ neostriatal interneuronal ensemble in normal mouse and after injury of the nigrostriatal pathway. J Neurosci, 32(3), 864-872. doi:10.1523/JNEUROSCI.2693-11.2012 Hughes, A. J., Colosimo, C., Kleedorfer, B., Daniel, S. E., & Lees, A. J. (1992). The dopaminergic response in multiple system atrophy. J Neurol Neurosurg Psychiatry, 55(11), 1009-1013. Kahle, P. J. (2008). alpha-Synucleinopathy models and human neuropathology: similarities and differences. Acta Neuropathol, 115(1), 87-95. doi:10.1007/s00401-007-0302-x Kaindlstorfer, C., Garcia, J., Winkler, C., Wenning, G. K., Nikkhah, G., & Dobrossy, M. D. (2012). Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy. J Neurosci Res, 90(6), 1284-1295. doi:10.1002/jnr.23021 Kamp, F., Exner, N., Lutz, A. K., Wender, N., Hegermann, J., Brunner, B., . . . Haass, C. (2010). Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J, 29(20), 3571-3589. doi:10.1038/emboj.2010.223 Kapur, S. K., & Katz, A. J. (2013). Review of the adipose derived stem cell secretome. Biochimie, 95(12), 2222-2228. doi:10.1016/j.biochi.2013.06.001 Karpinar, D. P., Balija, M. B., Kugler, S., Opazo, F., Rezaei-Ghaleh, N., Wender, N., . . . Zweckstetter, M. (2009). Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models. EMBO J, 28(20), 3256-3268. doi:10.1038/emboj.2009.257 Kaufmann, H., Freeman, R., Biaggioni, I., Low, P., Pedder, S., Hewitt, L. A., . . . Investigators, N. O. H. (2014). Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology, 83(4), 328-335. doi:10.1212/WNL.0000000000000615 Kirik, D., Rosenblad, C., & Bjorklund, A. (1998). Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol, 152(2), 259-277. doi:10.1006/exnr.1998.6848 Kollensperger, M., Stefanova, N., Reindl, M., Poewe, W., & Wenning, G. K. (2007). Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy. Mov Disord, 22(3), 353-358. doi:10.1002/mds.21251 Kumar, R., Agarwal, A. K., & Seth, P. K. (1995). Free radical-generated neurotoxicity of 6-hydroxydopamine. J Neurochem, 64(4), 1703-1707. Lee, P. H., Lee, J. E., Kim, H. S., Song, S. K., Lee, H. S., Nam, H. S., . . . Sohn, Y. H. (2012). A randomized trial of mesenchymal stem cells in multiple system atrophy. Ann Neurol, 72(1), 32-40. doi:10.1002/ana.23612 Liqing, Y., Jia, G., Jiqing, C., Ran, G., Fei, C., Jie, K., . . . Cheng, Z. (2011). Directed differentiation of motor neuron cell-like cells from human adipose-derived stem cells in vitro. Neuroreport, 22(8), 370-373. doi:10.1097/WNR.0b013e3283469615 Low, P. A., Robertson, D., Gilman, S., Kaufmann, H., Singer, W., Biaggioni, I., . . . Galpern, W. R. (2014). Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol, 13(3), 268-275. doi:10.1016/S1474-4422(13)70301-6 Maruyama, W., Nitta, A., Shamoto-Nagai, M., Hirata, Y., Akao, Y., Yodim, M., . . . Naoi, M. (2004). N-Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-kappaB transcription factor. Neurochem Int, 44(6), 393-400. Mishizen-Eberz, A. J., Norris, E. H., Giasson, B. I., Hodara, R., Ischiropoulos, H., Lee, V. M., . . . Lynch, D. R. (2005). Cleavage of alpha-synuclein by calpain: potential role in degradation of fibrillized and nitrated species of alpha-synuclein. Biochemistry, 44(21), 7818-7829. doi:10.1021/bi047846q Monville, C., Torres, E. M., & Dunnett, S. B. (2006). Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J Neurosci Methods, 158(2), 219-223. doi:10.1016/j.jneumeth.2006.06.001 Mosharov, E. V., Staal, R. G., Bove, J., Prou, D., Hananiya, A., Markov, D., . . . Sulzer, D. (2006). Alpha-synuclein overexpression increases cytosolic catecholamine concentration. J Neurosci, 26(36), 9304-9311. doi:10.1523/JNEUROSCI.0519-06.2006 Na Kim, H., Yeol Kim, D., Hee Oh, S., Sook Kim, H., Suk Kim, K., & Hyu Lee, P. (2017). Feasibility and Efficacy of Intra-Arterial Administration of Mesenchymal Stem Cells in an Animal Model of Double Toxin-Induced Multiple System Atrophy. Stem Cells Transl Med, 6(5), 1424-1433. doi:10.1002/sctm.16-0438 Nakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., . . . Edwards, R. H. (2011). Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem, 286(23), 20710-20726. doi:10.1074/jbc.M110.213538 Ng, T. K., Fortino, V. R., Pelaez, D., & Cheung, H. S. (2014). Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J Stem Cells, 6(2), 111-119. doi:10.4252/wjsc.v6.i2.111 Papapetropoulos, S., Tuchman, A., Laufer, D., Papatsoris, A. G., Papapetropoulos, N., & Mash, D. C. (2007). Causes of death in multiple system atrophy. J Neurol Neurosurg Psychiatry, 78(3), 327-329. doi:10.1136/jnnp.2006.103929 Park, H. J., Shin, J. Y., Kim, H. N., Oh, S. H., & Lee, P. H. (2014). Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model. Neurobiol Aging, 35(8), 1920-1928. doi:10.1016/j.neurobiolaging.2014.01.028 Park, H. J., Shin, J. Y., Lee, B. R., Kim, H. O., & Lee, P. H. (2012). Mesenchymal stem cells augment neurogenesis in the subventricular zone and enhance differentiation of neural precursor cells into dopaminergic neurons in the substantia nigra of a parkinsonian model. Cell Transplant, 21(8), 1629-1640. doi:10.3727/096368912X640556 Pinton, P., Giorgi, C., Siviero, R., Zecchini, E., & Rizzuto, R. (2008). Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene, 27(50), 6407-6418. doi:10.1038/onc.2008.308 Poewe, W., Mahlknecht, P., & Krismer, F. (2015). Therapeutic advances in multiple system atrophy and progressive supranuclear palsy. Mov Disord, 30(11), 1528-1538. doi:10.1002/mds.26334 Poewe, W., Seppi, K., Fitzer-Attas, C. J., Wenning, G. K., Gilman, S., Low, P. A., . . . Rasagiline-for, M. S. A. i. (2015). Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial. Lancet Neurol, 14(2), 145-152. doi:10.1016/S1474-4422(14)70288-1 Rice, C. M., Kemp, K., Wilkins, A., & Scolding, N. J. (2013). Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases. Lancet, 382(9899), 1204-1213. doi:10.1016/S0140-6736(13)61810-3 Rozas, G., & Labandeira Garcia, J. L. (1997). Drug-free evaluation of rat models of parkinsonism and nigral grafts using a new automated rotarod test. Brain Res, 749(2), 188-199. doi:10.1016/S0006-8993(96)01162-6 Ruetze, M., & Richter, W. (2014). Adipose-derived stromal cells for osteoarticular repair: trophic function versus stem cell activity. Expert Rev Mol Med, 16, e9. doi:10.1017/erm.2014.9 Scholz, S. W., Houlden, H., Schulte, C., Sharma, M., Li, A., Berg, D., . . . Gasser, T. (2009). SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol, 65(5), 610-614. doi:10.1002/ana.21685 Senarath-Yapa, K., McArdle, A., Renda, A., Longaker, M. T., & Quarto, N. (2014). Adipose-derived stem cells: a review of signaling networks governing cell fate and regenerative potential in the context of craniofacial and long bone skeletal repair. Int J Mol Sci, 15(6), 9314-9330. doi:10.3390/ijms15069314 Solano, S. M., Miller, D. W., Augood, S. J., Young, A. B., & Penney, J. B., Jr. (2000). Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann Neurol, 47(2), 201-210. Stagg, J. (2007). Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens, 69(1), 1-9. doi:10.1111/j.1399-0039.2006.00739.x Stefanova, N., Tison, F., Reindl, M., Poewe, W., & Wenning, G. K. (2005). Animal models of multiple system atrophy. Trends Neurosci, 28(9), 501-506. doi:10.1016/j.tins.2005.07.002 Stefanova, N., & Wenning, G. K. (2015). Animal models of multiple system atrophy. Clin Auton Res, 25(1), 9-17. doi:10.1007/s10286-014-0266-6 Sun, H., Hou, Z., Yang, H., Meng, M., Li, P., Zou, Q., . . . Xiao, Z. (2014). Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model. Cell Tissue Res, 357(3), 571-582. doi:10.1007/s00441-014-1903-z Tomac, A., Lindqvist, E., Lin, L. F., Ogren, S. O., Young, D., Hoffer, B. J., & Olson, L. (1995). Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature, 373(6512), 335-339. doi:10.1038/373335a0 Tomac, A., Widenfalk, J., Lin, L. F., Kohno, T., Ebendal, T., Hoffer, B. J., & Olson, L. (1995). Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A, 92(18), 8274-8278. Ubhi, K., Rockenstein, E., Mante, M., Inglis, C., Adame, A., Patrick, C., . . . Masliah, E. (2010). Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci, 30(18), 6236-6246. doi:10.1523/JNEUROSCI.0567-10.2010 Vekrellis, K., Rideout, H. J., & Stefanis, L. (2004). Neurobiology of alpha-synuclein. Mol Neurobiol, 30(1), 1-21. doi:10.1385/MN:30:1:001 Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008). Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem, 283(35), 23542-23556. doi:10.1074/jbc.M801992200 Wagers, A. J., & Weissman, I. L. (2004). Plasticity of adult stem cells. Cell, 116(5), 639-648. Watanabe, H., Saito, Y., Terao, S., Ando, T., Kachi, T., Mukai, E., . . . Sobue, G. (2002). Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain, 125(Pt 5), 1070-1083. Weinreb, O., Amit, T., Bar-Am, O., & Youdim, M. B. (2007). Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy. Ann N Y Acad Sci, 1122, 155-168. doi:10.1196/annals.1403.011 Yager, L. M., Garcia, A. F., Wunsch, A. M., & Ferguson, S. M. (2015). The ins and outs of the striatum: role in drug addiction. Neuroscience, 301, 529-541. doi:10.1016/j.neuroscience.2015.06.033 Yoon, H. H., Kim, Y. H., Shin, E. S., & Jeon, S. R. (2014). A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic acid into the striatum. J Korean Med Sci, 29(11), 1555-1561. doi:10.3346/jkms.2014.29.11.1555
|